Capital Management Corp VA Has $8.38 Million Stock Holdings in CME Group Inc. $CME

Key Points

• Capital Management Corp VA reduced its holdings in CME Group Inc. by 6.2% in the second quarter, now owning 30,407 shares valued at approximately $8.38 million.
• Several institutional investors increased their stakes in CME Group during the second quarter, with Generali Asset Management boosting its position by 91.7%.
• CME Group announced a quarterly dividend of $1.25 per share, equating to an annualized yield of 1.9%, with a dividend payout ratio of 48.4%.

Capital Management Corp VA decreased its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 6.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,407 shares of the financial services provider's stock after selling 2,009 shares during the quarter. CME Group comprises approximately 1.4% of Capital Management Corp VA's investment portfolio, making the stock its 28th biggest holding. Capital Management Corp VA's holdings in CME Group were worth $8,381,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Generali Asset Management SPA SGR boosted its position in shares of CME Group by 91.7% during the second quarter. Generali Asset Management SPA SGR now owns 7,550 shares of the financial services provider's stock worth $2,081,000 after purchasing an additional 3,612 shares in the last quarter. Ritholtz Wealth Management lifted its holdings in CME Group by 22.6% during the second quarter. Ritholtz Wealth Management now owns 5,455 shares of the financial services provider's stock worth $1,503,000 after acquiring an additional 1,004 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. grew its stake in CME Group by 12.5% in the second quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 3,155 shares of the financial services provider's stock valued at $870,000 after acquiring an additional 350 shares during the period. Bayforest Capital Ltd acquired a new position in CME Group in the second quarter valued at about $114,000. Finally, Sagespring Wealth Partners LLC increased its holdings in shares of CME Group by 4.1% in the second quarter. Sagespring Wealth Partners LLC now owns 25,415 shares of the financial services provider's stock worth $7,005,000 after acquiring an additional 997 shares in the last quarter. Institutional investors own 87.75% of the company's stock.

Insiders Place Their Bets

In other news, Director William R. Shepard acquired 262 shares of the business's stock in a transaction that occurred on Thursday, September 25th. The shares were bought at an average price of $265.19 per share, with a total value of $69,479.78. Following the acquisition, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. The trade was a 0.10% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the company's stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,043 shares of company stock worth $3,527,956. Insiders own 0.30% of the company's stock.

CME Group Price Performance

Shares of CME opened at $267.18 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company's fifty day simple moving average is $268.22 and its 200 day simple moving average is $271.32. The company has a market cap of $96.29 billion, a price-to-earnings ratio of 25.86, a PEG ratio of 6.23 and a beta of 0.41. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.68 billion. During the same period in the prior year, the firm earned $2.56 EPS. The business's revenue was up 10.4% on a year-over-year basis. On average, research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is 48.40%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on CME shares. Raymond James Financial decreased their price objective on CME Group from $309.00 to $307.00 and set an "outperform" rating for the company in a research report on Monday. Oppenheimer lifted their price target on shares of CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Keefe, Bruyette & Woods increased their price objective on shares of CME Group from $283.00 to $287.00 and gave the stock a "market perform" rating in a research report on Monday. Citigroup upgraded shares of CME Group from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. Finally, TD Cowen upped their target price on shares of CME Group from $281.00 to $288.00 and gave the stock a "hold" rating in a research note on Wednesday, October 8th. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $283.71.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.